Hercules Capital, Inc.

Hercules Capital, Inc. is a prominent specialty finance company specializing in providing senior secured venture growth loans to high-growth, innovative companies across various sectors, including technology, life sciences, and sustainable and renewable technology. Since its inception in December 2003, Hercules has committed over $25 billion to more than 700 companies, establishing itself as a preferred lender for entrepreneurs and venture capital firms seeking growth capital financing. The company manages over $5 billion in assets and has a market capitalization exceeding $3 billion.

The firm's investment strategy focuses on delivering creative and flexible credit solutions that complement existing equity capital, offering highly customizable and less dilutive financing options. Hercules primarily invests in early-stage, growth, late-stage, and pre-IPO companies, providing capital to support expansion initiatives, mergers and acquisitions, working capital needs, and capital efficiency without dilutive equity funding. The company's expertise spans multiple industries, including technology, life sciences, and sustainable and renewable technology.

Hercules Capital operates through its wholly owned subsidiary, Hercules Adviser LLC, which manages investments for external parties. The company has a strong track record of supporting innovative firms, with notable portfolio companies such as Arcus Biosciences, Marathon Health, and Impossible Foods. With offices in San Mateo, Boston, New York, Denver, San Diego, Chicago, Westport, and London, Hercules Capital continues to empower innovators by providing flexible capital solutions tailored to the unique needs of each sector and company.